Fresenius Medical Care AG (FMS): EBITDA
Not updated since 2016-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$3.41B
Year ended 2016-12-31
+5.5%
3-year compound annual growth
+5.3%
5-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2016-12-31 | $3.41B | +12.1% | 2017-02-22, From 2016-01-01 |
| 2015-12-31 | $3.04B | +3.1% | 2017-02-22, From 2015-01-01 |
| 2014-12-31 | $2.95B | +1.7% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $2.90B | +2.9% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $2.82B | +7.2% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $2.63B | +8.5% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $2.43B | +9.7% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $2.21B | +6.0% | 2012-02-23, From 2009-01-01 |
| 2008-12-31 | $2.09B | +7.4% | 2011-03-25, From 2008-01-01 |
| 2007-12-31 | $1.94B | n/a | 2010-02-24, From 2007-01-01 |